Scilex Hldg patents expiration
1. Elyxyb patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10799517 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| US9949990 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| US10376527 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| US9795620 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| US9572819 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| US10722456 | SCILEX HLDG | Oral composition of celecoxib for treatment of pain |
May, 2036
(12 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 05, 2023 |
Drugs and Companies using CELECOXIB ingredient
Market Authorisation Date: 05 May, 2020
Treatment: Acute treatment of migraine with or without aura in adults
Dosage: SOLUTION;ORAL
More Information on Dosage
ELYXYB family patents
